New Delhi: Covid-19 vaccine available in India is expected to minimize the impact of infection in individuals, and also reduces the possibility of requiring intensive care.
The World Health Organization (WHO) has clarified that a person can be infected with SARS-COV-2 before or after vaccination and still ill with Covid-19.
Reports show that Covid breakthrough cases are generally recorded among people after they receive a second dose of covaxin or covishield.
A survey was conducted by localcirlles, to better understand what residents have experienced after the first dose and both covishield vaccines.
70% of Indians who took the first dose of Covishield experienced no or lightweight side effects of 1% of citizens who took the covishield first to have a Covid infection afterwards.
On the other hand, 44% of residents surveyed said they did not experience side effects.
However, there are 13% of residents who say they experience (1) sick arms, 6% are (2) fatigue, and 9% suffer (3) fever.
Breaking polls, 7% experienced ‘1 & 2’ side effects of the options mentioned above, 6% face side effects ‘2 & 3’, while 14% face all side effects ‘1, 2 & 3’.
On the aggregate basis, 70% of the residents surveyed experienced no or lightweight side pain and fatigue – which were lightweight, after taking the first dose of covishield.
The question in this survey received 10,043 responses.
75% of Indians who take the second dose of Covishield experienced no or light side effects; 4% report Covid infection afterwards.
Only 1% of citizens who took the covishield both faced several serious conditions, and 4% had covid post-vaccine infections.
On the other hand, 56% of residents surveyed said they did not experience side effects.
There are 9% of residents who say they experience (1) sick arms, 5% are (2) fatigue, and 7% suffer (3) fever.
On the aggregate basis, 75% of residents surveyed experienced no or silent side pain and fatigue – which were lightweight, after taking the second dose of the covishield.
The question in this survey received 10,296 responses.
64% of Indians who took the first dose of Covaxin experienced no or lightweight side effects.
The next question in the survey sought to find out from citizens inoculated with the first dose of Covaxin experienced symptoms or side effects within 24-48 houses after taking Jab.
In response, only 1% of citizens who took Covaxin’s first coat faced several serious conditions.
On the other hand, 36% of residents surveyed said they did not experience side effects.
There are 15% of residents who say they experience (1) sick arms, 5% are (2) fatigue, and 18% have (3) fever.
On the aggregate basis, 64% of residents surveyed experienced no or arms or mild side exhausted – which are lightweight, after taking the first dose of Covaxin.
The question in this survey received 10,190 responses.
78% of Indians who take the second dose of Covaxin experienced no or lightweight side effects; 2% reported covid3% infection of citizens who took the covaxin second macemat facing several serious conditions, and 2% reported the post vaccine ‘Covid infection’.
On the other hand, 52% of residents surveyed said they did not experience side effects.
However, there are 10% of residents who say they experience (1) sick arms, 6% are (2) fatigue, and 8% suffer (3) fever.
On the aggregate basis, 78% of residents surveyed experienced no or arms or exhausted sides of the sore after taking the second dose of Covaxin.
The question in this survey received 10,108 responses.
A summary of conclusions, 70% of Indians after taking the first dose of covishield and 64% with covaxin experiencing no or lightweight side effects.
Similarly, 75% is inoculated with a second dose of covishield and 78% with covaxin experiencing no or lightweight side effects.
However, 4% of residents took the second dose of covishield and 2% with Covaxin had reported having a covid infection.
The majority of India experienced no or lightweight side effects after 2 doses of covishield and covaxin: report
